Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 1, 2010, Pages 35-43

  Singhal, Aparna ^a   Nagarajan, Rajakumar ^a   Hinkin, Charles H ^a,b   Kumar, Rajesh ^a   Sayre, James ^a   Elderkin Thompson, Virginia ^a   Huda, Amir ^a,c   Gupta, Rakesh K ^d   Han, Steven Huy ^a   Thomas, M Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

COSY; Liver disease; MRI; MRS; Neuropsychological scores

Indexed keywords

CHOLINE; CREATINE; GLUTAMINE; INOSITOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FRONTAL CORTEX; GLOBUS PALLIDUS; HEPATIC ENCEPHALOPATHY; HUMAN; INTERMETHOD COMPARISON; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL CORTEX; PRIORITY JOURNAL; IMAGE PROCESSING; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA;

FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77954101918     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22216     Document Type: Article

References (54)

1. Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2006;43: 1187-1190. (Pubitemid 43980095)
2. Kreis R, Farrow N, Ross BD. Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 1990;336:635-636. (Pubitemid 20296972)
3. Kreis R, Farrow N, Ross BD. Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991;4:109-116.
4. Albrecht J, Dolinska M. Glutamine as a pathogenic factor in hepatic encephalopathy. J Neurosci Res 2001;65:1-5. (Pubitemid 32601305)
5. Jalan R, Shawcross D, Davies N. The molecular pathogenesis of hepatic encephalopathy. Int J Biochem Cell Biol 2003;35:1175-1181.
6. Cordoba J, Gottstein J, Blei AT. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 1996;24:919-923. (Pubitemid 26334295)
7. Haussinger D, Laubenberger J, vom Dahl S, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-1480.
8. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006;43:698-706.
9. Inoue E, Hori S, Narumi Y, et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991;179:551-555.
10. Krieger S, Jauss M, Jansen O, et al. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 1996;111:147-155. (Pubitemid 26226894)
11. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
12. Kircheis G, Wettstein M, Timmermann L, et al. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002;35:357-366. (Pubitemid 34106375)
13. Naegele T, Grodd W, Viebahn R, et al. MR imaging and 1H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 2000;216:683-691.
14. Mechtcheriakov S, Graziadei IW, Mattedi M, et al. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl 2004;10:77-83.
15. Rose C, Jalan R. Is minimal hepatic encephalopathy completely reversible following liver transplantation? Liver Transpl 2004;10:84-87.
16. Kharbanda PS, Saraswat VA, Dhiman RK. Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods. Indian J Gastroenterol 2003;22(Suppl 2):S37-S41.
17. Mullen KD. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25(Suppl 1):11-16.
18. Binesh N, Huda A, Bugbee M, et al. Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy. J Magn Reson Imaging 2005;21:398-405. (Pubitemid 40446435)
19. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995. p 333-685.
20. Heaton RK, Grant I., Matthews C.G. Comprehensive norms for an expanded Halstead-Reitan battery: demographic corrections, research findings, and clinical applications. Odessa, FL: Psychological Assessment Resources; 1991.
21. Thomas MA, Yue K, Binesh N, et al. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med 2001;46:58-67.
22. Ogg RJ, Kingsley PB, Taylor JS. WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994;104:1-10.
23. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986;21:720-733.
24. Hartmann IJ, Groeneweg M, Quero JC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000;95:2029-2034.
25. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004;19:253-267.
26. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996;53:758-763. (Pubitemid 26266921)
27. Blei AT, Olafsson S, Therrien G, Butterworth RF. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994;19:1437-1444. (Pubitemid 24166466)
28. Huda A, Guze BH, Thomas A, et al. Clinical correlation of neuropsychological tests with 1H magnetic resonance spectroscopy in hepatic encephalopathy. Psychosom Med 1998;60:550-556. (Pubitemid 28453017)
29. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182:19-27.
30. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193:457-463. (Pubitemid 24338334)
31. Thomas MA, Huda A, Guze B, et al. Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy. AJR Am J Roentgenol 1998;171:1123-1130. (Pubitemid 28449988)
32. Taylor-Robinson SD, Sargentoni J, Oatridge A, et al. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 1996;11:249-268. (Pubitemid 26282643)
33. Bothwell JH, Rae C, Dixon RM, Styles P, Bhakoo KK. Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo. J Neurochem 2001;77:1632-1640. (Pubitemid 32574498)
34. Flogel U, Niendorf T, Serkowa N, et al. Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: a multinuclear NMR study. Neurochem Res 1995;20:793-802.
35. Freeman JJ. Regulatory mechanisms of choline production. Life Sci 1996;58:1921-1927.
36. Klein J, Gonzalez R, Koppen A, Loffelholz K. Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int 1993;22:293-300.
37. Albrecht J, Zielinska M. The role of inhibitory amino acidergic neurotransmission in hepatic encephalopathy: a critical overview. Metab Brain Dis 2002;17:283-294. (Pubitemid 36204758)
38. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992;72:101-163.
39. Butterworth RF. Neuroactive amino acids in hepatic encephalopathy. Metab Brain Dis 1996;11:165-173.
40. Wysmyk U, Oja SS, Saransaari P, Albrecht J. Long-term treatment with ammonia affects the content and release of taurine in cultured cerebellar astrocytes and granule neurons. Neurochem Int 1994;24:317-322.
41. Hilgier W, Olson JE. Brain ion and amino acid contents during edema development in hepatic encephalopathy. J Neurochem 1994;62:197-204.
42. Zielinska M, Hilgier W, Borkowska HD, et al. Ammonia-induced extracellular accumulation of taurine in the rat striatum in vivo: role of ionotropic glutamate receptors. Neurochem Res 2002;27:37-42.
43. Sergeeva OA, Chepkova AN, Doreulee N, et al. Taurine-induced long-lasting enhancement of synaptic transmission in mice: role of transporters. J Physiol 2003;550:911-919. (Pubitemid 37010073)
44. Sergeeva OA, Fleischer W, Chepkova AN, et al. GABAA-receptor modification in taurine transporter knockout mice causes striatal disinhibition. J Physiol 2007;585:539-548. (Pubitemid 350193923)
45. Vinnakota S, Qian X, Egal H, Sarthy V, Sarkar HK. Molecular characterization and in situ localization of a mouse retinal taurine transporter. J Neurochem 1997;69:2238-2250. (Pubitemid 27495408)
46. Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995;346:270-274.
47. Maeda H, Sato M, Yoshikawa A, et al. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology 1997;39:546-550. (Pubitemid 27338537)
48. Brunberg JA, Kanal E, Hirsch W, Van Thiel DH. Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. AJNR Am J Neuroradiol 1991;12:909-914.
49. Kulisevsky J, Pujol J, Balanzo J, et al. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology 1992;16:1382-1388.
50. Fukuzawa T, Matsutani S, Maruyama H, et al. Magnetic resonance images of the globus pallidus in patients with idiopathic portal hypertension: a quantitative analysis of the relationship between signal intensity and the grade of portosystemic shunt. J Gastroenterol Hepatol 2006;21:902-907.
51. Morgan MY. Noninvasive neuroinvestigation in liver disease. Semin Liver Dis 1996;16:293-314.
52. Geissler A, Lock G, Frund R, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997;25:48-54.
53. Butterworth RF. Taurine in hepatic encephalopathy. Adv Exp Med Biol 1996;403:601-606.
54. Schulte RF and Boesiger P. ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed 2006;19:255-263.